There are 2949 resources available
HER past: Looking back on two decades of HER2-targeted therapy
Presenter: Fatima Cardoso
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
HER new potential: New advances in HER2+ breast cancer treatment
Presenter: Erika Hamilton
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Sharing HER experience: Case-based panel discussion
Presenter: Erika Hamilton
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Closing remarks
Presenter: Eva Ciruelos
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Emerging research with immune checkpoint inhibitors in basal cell carcinoma (BCC)
Presenter: Susana Puig
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Welcome and Introduction
Presenter: Robert Coleman
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Live Q&A - 28 September 2020 - 17:00-17:30
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Javier Cortés
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast
Welcome introduction and objectives and Treatment for locally advanced/metastatic cutaneous squamous cell carcinoma (CSCC)
Presenter: Chrysalyne Schmults
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:30-16:00
Presenter: Ana Oaknin
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast